Trial Profile
A Study Evaluating the Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia and Improvement of Quality of Life for Individuals with Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder
- Focus Adverse reactions; Therapeutic Use
- 22 May 2018 New trial record
- 21 May 2018 Results presented at the 113th Annual Meeting of the American Urological Association.